Skip to main content
HR 4098 109th Congress House Health Cancer Chemotherapy Clinical trials Congress Congressional investigations Congressional reporting requirements Drugs Medical fees Medical research Medicare Overhead costs Performance measurement Physicians Prescription pricing Quality of care Science, Technology, Communications Social Welfare

Community Cancer Care Preservation Act of 2005

Introduced: October 20, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 4, 2005
Referred to the Subcommittee on Health.
Oct 20, 2005
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Community Cancer Care Preservation Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to subject to quarterly reconciliation any payments to physicians for drugs or biologicals made according to average sales price payment methodology in order to assure that they do not exceed or fall short of the actual average sales price during any preceding period.

Requires the Secretary of Health and Human Services to review all such payments in the preceding quarter and compare them to the verified average sales price reported by the manufacturer for such quarter.

Removes prompt pay discounts from the calculation of the manufacturer's average sales price.

Extends through December 31, 2006, the current demonstration project to identify and assess oncology services that positively affect cancer outcomes.

Requires the Secretary to make an additional 2% for drug administration services payment to physicians for overhead and related costs.

Directs the Secretary to develop indicators for the evaluation of the quality of oncology services provided in the physician office setting.

Requires the Director of the National Cancer Institute to develop a strategic plan to increase the number of cancer patients who enroll in clinical trials.

What's happening now November 4, 2005

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3
 Cosponsors 16
All 16 Democratic 7 Republican 9